NICOLE SMITH: Open Payments
NPI 1952959751 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,267 in 63 payments from 19 companies in 2025. Trend: 2023 $1,823 · 2024 $2,063 · 2025 $1,267
Food & beverage: $1,267
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $273 |
| ABBVIE INC. | 10 | $151 |
| Otsuka America Pharmaceutical, Inc. | 13 | $145 |
| PFIZER INC. | 7 | $144 |
| Novo Nordisk Inc | 6 | $119 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Exact Sciences Corporation | 3 | $53 |
| Lilly USA, LLC | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
Products named: BREZTRI, REXULTI, NURTEC ODT, XIFAXAN, QULIPTA, VRAYLAR, Kerendia, Wegovy.
Industry payments across OH — which companies pay providers there.
